Prescription Drugs - Sudan

  • Sudan
  • In Sudan, the revenue in the Prescription Drugs market is expected to reach US$94.96m in 2024.
  • It is projected to show an annual growth rate (CAGR 2024-2029) of -4.37%, resulting in a market volume of US$75.93m by 2029.
  • Compared to other countries around Worldwide, United States is expected to generate the highest revenue in the Prescription Drugs market, reaching US$358.90bn in 2024.
  • When considering the population figures, in Sudan, per person revenues of US$1.92 are generated in 2024.
  • Sudan's prescription drug market is experiencing a surge in demand due to an aging population and increased prevalence of chronic diseases.

Key regions: Japan, China, Europe, Australia, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Prescription Drugs (Pharmacies) market in Sudan is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trajectory. Customer preferences play a crucial role in shaping the Prescription Drugs (Pharmacies) market in Sudan. Consumers are increasingly seeking convenient and accessible healthcare services, including easy access to prescription drugs. This has led to a growing demand for pharmacies that offer a wide range of prescription medications and provide efficient and reliable services. Additionally, customers are becoming more health-conscious and are actively seeking out pharmacies that offer quality and affordable prescription drugs. Several trends are driving the growth of the Prescription Drugs (Pharmacies) market in Sudan. Firstly, there is an increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and respiratory illnesses. As a result, the demand for prescription drugs to manage these conditions is on the rise. Moreover, the aging population in Sudan is also contributing to the growth of the market, as older individuals tend to require more prescription medications to manage their health. Local special circumstances in Sudan further contribute to the development of the Prescription Drugs (Pharmacies) market. The country has a large rural population with limited access to healthcare facilities. As a result, pharmacies play a crucial role in providing essential medications to these underserved areas. Additionally, the government of Sudan has implemented policies to improve access to healthcare services, including the provision of prescription drugs. This supportive regulatory environment has created opportunities for pharmacies to expand their operations and cater to the growing demand for prescription medications. Underlying macroeconomic factors also play a significant role in the development of the Prescription Drugs (Pharmacies) market in Sudan. The country has experienced steady economic growth in recent years, leading to an increase in disposable income among the population. This has resulted in a higher ability to afford prescription medications, driving the demand for pharmacies. Moreover, Sudan has witnessed an increase in foreign direct investment, which has led to improved infrastructure and healthcare facilities, further supporting the growth of the Prescription Drugs (Pharmacies) market. In conclusion, the Prescription Drugs (Pharmacies) market in Sudan is experiencing growth and development due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. As consumers seek convenient and accessible healthcare services, the demand for pharmacies that offer a wide range of prescription medications and reliable services is increasing. The prevalence of chronic diseases, the aging population, and supportive government policies further contribute to the growth of the market. Additionally, Sudan's steady economic growth and increased foreign direct investment have improved access to healthcare facilities and affordability of prescription drugs.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)